Appetite suppression and weight loss after the cannabinoid antagonist SR 141716.

[1]  G. Gessa,et al.  Cannabinoid modulation of intestinal propulsion in mice. , 1998, European journal of pharmacology.

[2]  P. Soubrié,et al.  Involvement of central cannabinoid (CB1) receptors in the establishment of place conditioning in rats , 1998, Psychopharmacology.

[3]  P. Soubrié,et al.  Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors , 1997, Psychopharmacology.

[4]  C. Ashby,et al.  Electrically evoked acetylcholine release from hippocampal slices is inhibited by the cannabinoid receptor agonist, WIN 55212-2, and is potentiated by the cannabinoid antagonist, SR 141716A. , 1996, The Journal of pharmacology and experimental therapeutics.

[5]  J. Lowe,et al.  In vivo characterization of a specific cannabinoid receptor antagonist (SR141716A): inhibition of delta 9-tetrahydrocannabinol-induced responses and apparent agonist activity. , 1996, The Journal of pharmacology and experimental therapeutics.

[6]  L. Shaw,et al.  Cannabinoids and appetite stimulation , 1994, Pharmacology Biochemistry and Behavior.

[7]  P. Soubrié,et al.  SR141716A, a potent and selective antagonist of the brain cannabinoid receptor , 1994, FEBS letters.

[8]  S. Almog,et al.  Two new unsaturated fatty acid ethanolamides in brain that bind to the cannabinoid receptor. , 1993, Journal of medicinal chemistry.

[9]  D. Gibson,et al.  Isolation and structure of a brain constituent that binds to the cannabinoid receptor. , 1992, Science.

[10]  A. Howlett,et al.  Determination and characterization of a cannabinoid receptor in rat brain. , 1988, Molecular pharmacology.